triamcinolone acetonide has been researched along with Day Blindness in 36 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (2.78) | 18.2507 |
2000's | 15 (41.67) | 29.6817 |
2010's | 19 (52.78) | 24.3611 |
2020's | 1 (2.78) | 2.80 |
Authors | Studies |
---|---|
Chen, Y; Duan, M; Fang, HY; Jin, ZY; Meng, W; Wang, YN; Xu, DD; Zhang, ZH; Zhou, HL | 1 |
Guo, C; Qiu, J; Yang, L; Zhu, L; Zhu, R | 1 |
Ganne, P; Krishnappa, NC | 1 |
Ratra, D; Ratra, V; Shah, H | 1 |
Ali, MH; Goerlitz-Jessen, M; Grewal, DS | 1 |
Dhawan, A; Shukla, D | 1 |
Jia, Y; Miao, H; Wang, L; Yang, Y; Zhang, XY; Zhou, YS | 1 |
Chawla, R; Gaur, N; Singh, P; Takkar, B | 1 |
Stoffelns, BM | 1 |
Schulze-Döbold, C; Weber, M | 1 |
Durmaz, S; Kandemir, N; Kocabora, MS | 1 |
Smiddy, WE | 2 |
Apte, RS | 1 |
Blodi, BA; Chan, CK; Fisher, M; Gonzalez, VH; Ip, MS; Oden, NL; Scott, IU; Singerman, LJ; Tolentino, M; VanVeldhuisen, PC | 2 |
Aiello, LP; Beck, RW; Bressler, NM; Davis, MD; Edwards, AR; Ferris, F; Glassman, AR; Ip, MS; Miller, KM | 1 |
Chan, RP; Chan, WM; Lai, TY; Lam, CP; Lam, DS; Liu, DT; Luk, FO | 1 |
Folk, JC; Jakovic, N; Jaksic, VZ; Milenkovic, SM; Paovic, JD; Risimic, DS; Stefanovic, IB | 1 |
Grabska-Liberek, I; Jamrozy-Witkowska, A; Kowalska, K; Oficjalska-Młyńczak, J | 1 |
Göbel, W; Guthoff, R; Hennemann, K; Meigen, T; Schrader, W | 1 |
Blodi, BA; Cohen, G; Hartnett, ME; Ip, MS; Oden, NL; Scott, IU; VanVeldhuisen, PC | 1 |
Fujioka, C; Furuta, M; Matsubara, H; Matsumoto, T; Matsuura, M; Sasoh, M; Sugimoto, M; Uji, Y; Wada, H | 1 |
Krummenauer, F; Lösche, CC; Schmidt, B | 1 |
Daly, MK; Freddo, T; McKnight, CJ; Shukla, AN | 1 |
Basu, S; Haque, MN; Kesarwani, S; Padhi, TR | 1 |
Allam, SS; Batchelet, AR; Compton, MW; Ghazi, NG; Patrie, J; Salti, HI; Scruggs, RT | 1 |
Church, CA; Hedayi, R; Martin, PA; Petti, GH | 1 |
Billson, F; Chua, W; Gillies, MC; Hunyor, AB; Luo, W; Mitchell, P; Penfold, P; Simpson, JM | 1 |
Belmont, JB; Martidis, A; Nelson, ML; Regillo, CD; Sivalingam, A; Tennant, MT | 1 |
Barnes, CH; Bowie, EM; Folk, JC | 1 |
Angerman, S; Kytö, JP; Lumiste, E; Paloheimo, M; Summanen, PA | 1 |
Shimura, M; Shiono, T; Yasuda, K | 1 |
Gonzales, CR; Quiram, PA; Schwartz, SD | 1 |
Barthelmes, D; Fleischhauer, JC; Helbig, H; Kurz-Levin, MM; Scherrer, M; Sutter, FK | 1 |
Helm, CJ; Holland, GN | 1 |
1 review(s) available for triamcinolone acetonide and Day Blindness
Article | Year |
---|---|
Acute idiopathic frosted branch angiitis in an 11-month-old infant treated with intravitreal triamcinolone acetonide.
Topics: Anti-Inflammatory Agents; Humans; Infant; Intravitreal Injections; Macular Edema; Male; Retinal Vasculitis; Triamcinolone Acetonide; Vision Disorders | 2012 |
7 trial(s) available for triamcinolone acetonide and Day Blindness
Article | Year |
---|---|
A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlus
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Observation; Prospective Studies; Retinal Vein Occlusion; Retreatment; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vision Disorders; Visual Acuity; Vitreous Body | 2009 |
A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlu
Topics: Adult; Aged; Aged, 80 and over; Double-Blind Method; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Prospective Studies; Retinal Vein Occlusion; Retreatment; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vision Disorders; Visual Acuity; Vitreous Body; Young Adult | 2009 |
Factors associated with improvement and worsening of visual acuity 2 years after focal/grid photocoagulation for diabetic macular edema.
Topics: Diabetic Retinopathy; Female; Glucocorticoids; Humans; Laser Coagulation; Macular Edema; Male; Middle Aged; Prospective Studies; Risk Factors; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vision Disorders; Visual Acuity | 2010 |
[Prognostic factors for visual outcome after intravitreal drug therapy for chronic diabetic macular oedema].
Topics: Aged; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Chronic Disease; Diabetic Retinopathy; Drug Therapy, Combination; Female; Humans; Intravitreal Injections; Macular Edema; Male; Prognosis; Treatment Outcome; Triamcinolone Acetonide; Vision Disorders; Visual Acuity | 2011 |
Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: Standard Care Versus COrticosteroid for REtinal Vein Occlusion Study report 10.
Topics: Anthropometry; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Laser Coagulation; Macular Edema; Prognosis; Retina; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vision Disorders; Visual Acuity | 2011 |
A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results.
Topics: Aged; Choroidal Neovascularization; Double-Blind Method; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Degeneration; Male; Prospective Studies; Safety; Triamcinolone Acetonide; Vision Disorders; Visual Acuity; Vitreous Body | 2003 |
Posterior sub-Tenon's capsule injection of triamcinolone acetonide prevents panretinal photocoagulation-induced visual dysfunction in patients with severe diabetic retinopathy and good vision.
Topics: Aged; Connective Tissue; Diabetic Retinopathy; Eye; Female; Fovea Centralis; Glucocorticoids; Humans; Injections; Light Coagulation; Male; Middle Aged; Preoperative Care; Prospective Studies; Retina; Severity of Illness Index; Tomography, Optical Coherence; Triamcinolone Acetonide; Vision Disorders; Vision, Ocular | 2006 |
28 other study(ies) available for triamcinolone acetonide and Day Blindness
Article | Year |
---|---|
Triamcinolone acetonide injection in the treatment of upper eyelid retraction in Graves' ophthalmopathy evaluated by 3.0 Tesla magnetic resonance imaging.
Topics: Conjunctiva; Eyelid Diseases; Humans; Lipopolysaccharides; Magnetic Resonance Imaging; Retrospective Studies; Triamcinolone Acetonide; Vision Disorders | 2022 |
Subretinal echinococcosis: a case report.
Topics: Adult; Angiogenesis Inhibitors; Combined Modality Therapy; Echinococcosis; Echinococcosis, Pulmonary; Eye Infections, Parasitic; Glucocorticoids; Humans; Magnetic Resonance Imaging; Male; Panuveitis; Prednisolone; Ranibizumab; Retinal Diseases; Tomography, Optical Coherence; Tomography, X-Ray Computed; Triamcinolone Acetonide; Vision Disorders; Visual Acuity; Vitrectomy | 2017 |
Paraproteinemic Maculopathy in a 63-Year-Old Man.
Topics: Angiogenesis Inhibitors; Bevacizumab; Blood Protein Electrophoresis; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glucocorticoids; Humans; Intravitreal Injections; Male; Middle Aged; Multiple Myeloma; Paraproteinemias; Retinal Diseases; Stroke; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Vision Disorders; Visual Acuity | 2018 |
Vitreous opacities after intravitreal triamcinolone injection- a case report.
Topics: Adult; Aged; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Tomography, Optical Coherence; Triamcinolone Acetonide; Vision Disorders; Visual Acuity; Vitreous Body | 2018 |
Rare Complication of Sclerochoroidal Calcifications.
Topics: Aged; Angiogenesis Inhibitors; Calcinosis; Calcium; Choroid Diseases; Choroidal Neovascularization; Coloring Agents; Epiretinal Membrane; Female; Fluorescein Angiography; Glucocorticoids; Humans; Indocyanine Green; Macular Edema; Parathyroid Hormone; Retinal Drusen; Scleral Diseases; Tomography, Optical Coherence; Triamcinolone Acetonide; Ultrasonography; Vision Disorders; Visual Fields; Vitamin D | 2019 |
Combined occlusion of branch retinal artery and vein secondary to prepapillary arterial loops.
Topics: Combined Modality Therapy; Eye Abnormalities; Fluorescein Angiography; Glucocorticoids; Humans; Intravitreal Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Optic Disk; Retinal Artery; Retinal Artery Occlusion; Retinal Vein Occlusion; Tomography, Optical Coherence; Triamcinolone Acetonide; Vision Disorders | 2015 |
[Clinical characteristics of 4 cases of scleritis associated with systemic lupus erythematosus].
Topics: Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Antinuclear; Arthritis; Cyclophosphamide; Disease Progression; Female; Hematologic Diseases; Humans; Isoxazoles; Leflunomide; Lung Diseases, Interstitial; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Middle Aged; Pain; Prognosis; Raynaud Disease; Recurrence; Scleritis; Serositis; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Vision Disorders | 2016 |
Triamcinolone emboli leading to central retinal artery occlusion: a multimodal imaging study.
Topics: Anti-Inflammatory Agents; Embolism; Humans; Injections, Intra-Articular; Male; Retinal Artery; Retinal Artery Occlusion; Temporomandibular Joint; Triamcinolone Acetonide; Vision Disorders; Young Adult | 2017 |
[Central Retinal Vein Occlusion accompanied by positive testing of serum antineutrophil cytoplasmic antibodies (c-ANCA)].
Topics: Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Aspirin; Combined Modality Therapy; Fluorescein Angiography; Granulomatosis with Polyangiitis; Hemodilution; Humans; Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Triamcinolone Acetonide; Vasculitis; Vision Disorders; Vitreous Body | 2008 |
Loss of visual function after repeated intravitreal injections of triamcinolone acetonide in refractory uveitic macular oedema.
Topics: Electroretinography; Glucocorticoids; Humans; Injections, Intraocular; Macular Edema; Male; Middle Aged; Tomography, Optical Coherence; Triamcinolone Acetonide; Uveitis; Vision Disorders; Vitreous Body | 2009 |
Exacerbation of central serous chorioretinopathy following intravitreal triamcinolone injection.
Topics: Choroid Diseases; Disease Progression; Fluorescein Angiography; Fundus Oculi; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Recurrence; Retinal Detachment; Retinal Diseases; Retinal Vein Occlusion; Time Factors; Tomography, Optical Coherence; Triamcinolone Acetonide; Vision Disorders; Visual Acuity; Vitreous Body | 2008 |
Economic implications of current age-related macular degeneration treatments.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Combined Modality Therapy; Cost-Benefit Analysis; Drug Therapy, Combination; Glucocorticoids; Health Care Costs; Humans; Macular Degeneration; Models, Economic; Photochemotherapy; Ranibizumab; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Vision Disorders; Visual Acuity | 2009 |
SCOREing in retinal venous occlusive disease.
Topics: Clinical Trials as Topic; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Prospective Studies; Retinal Vein Occlusion; Retreatment; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vision Disorders; Visual Acuity; Vitreous Body | 2009 |
Photodynamic therapy with or without intravitreal triamcinolone acetonide for symptomatic polypoidal choroidal vasculopathy.
Topics: Aged; Cataract; Choroid; Choroid Diseases; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Male; Middle Aged; Ocular Hypertension; Peripheral Vascular Diseases; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retrospective Studies; Time Factors; Treatment Outcome; Triamcinolone Acetonide; Verteporfin; Vision Disorders; Visual Acuity | 2010 |
Diagnostic and therapeutic challenges.
Topics: Choroiditis; Cyclosporine; Drug Therapy, Combination; Fluorescein Angiography; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Triamcinolone Acetonide; Vision Disorders; Visual Acuity | 2010 |
[Endophthalmitis following intravitreal triamcinolone acetonid injection--a case report].
Topics: Diabetic Retinopathy; Endophthalmitis; Female; Glucocorticoids; Humans; Injections, Intraocular; Macular Edema; Middle Aged; Staphylococcal Infections; Staphylococcus epidermidis; Triamcinolone Acetonide; Vision Disorders; Visual Acuity | 2010 |
[Case of systemic lupus erythematosus showing visual disturbances resulting from multiple ocular complications].
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Diagnostic Techniques, Ophthalmological; Female; Humans; Lupus Erythematosus, Systemic; Macular Edema; Magnetic Resonance Imaging; Methylprednisolone; Optic Neuropathy, Ischemic; Platelet Aggregation Inhibitors; Pulse Therapy, Drug; Retinal Diseases; Treatment Outcome; Triamcinolone Acetonide; Vision Disorders | 2011 |
[Evaluation of possible prognostic factors for the course of visual acuity after intravitreal ttriamconolone acetonide].
Topics: Aged; Anti-Inflammatory Agents; Female; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Prognosis; Treatment Outcome; Triamcinolone Acetonide; Vision Disorders; Visual Acuity | 2012 |
Intraocular ophthalmic ointment following anterior segment surgery.
Topics: Aged; Anterior Eye Segment; Drug Therapy, Combination; Eye Foreign Bodies; Gonioscopy; Humans; Lens Implantation, Intraocular; Macular Edema; Magnetic Resonance Spectroscopy; Male; Ointments; Petrolatum; Phacoemulsification; Prednisolone; Triamcinolone Acetonide; Vision Disorders | 2011 |
Clinical applications of cost analysis of diabetic macular edema treatments.
Topics: Aged; Angiogenesis Inhibitors; Clinical Trials as Topic; Cost-Benefit Analysis; Diabetic Retinopathy; Health Care Costs; Humans; Laser Coagulation; Macular Edema; Middle Aged; Quality-Adjusted Life Years; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Triamcinolone Acetonide; Vision Disorders; Visual Acuity | 2012 |
Diabetic macular edema.
Topics: Angiogenesis Inhibitors; Combined Modality Therapy; Diabetic Retinopathy; Fluorescein Angiography; Glucocorticoids; Humans; Intravitreal Injections; Laser Coagulation; Macular Edema; Tomography, Optical Coherence; Triamcinolone Acetonide; Vision Disorders; Visual Acuity | 2012 |
Visual loss after intraturbinate steroid injection.
Topics: Adult; Anti-Inflammatory Agents; Embolism; Fluorescein Angiography; Humans; Injections; Macula Lutea; Male; Radiography; Retinal Artery; Rhinitis, Allergic, Perennial; Severity of Illness Index; Triamcinolone Acetonide; Turbinates; Vision Disorders; Visual Acuity | 2003 |
Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Female; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Pain; Staphylococcal Infections; Staphylococcus epidermidis; Time Factors; Triamcinolone Acetonide; Vision Disorders; Vitreous Body | 2003 |
Corticosteroids, central serous chorioretinopathy, and neurocysticercosis.
Topics: Adult; Albendazole; Anticonvulsants; Antiprotozoal Agents; Body Fluids; Combined Modality Therapy; Drug Therapy, Combination; Exudates and Transudates; Fluorescein Angiography; Glucocorticoids; Humans; Magnetic Resonance Imaging; Male; Neurocysticercosis; Phenytoin; Prednisolone; Retinal Diseases; Triamcinolone Acetonide; Ventriculoperitoneal Shunt; Vision Disorders; Visual Acuity | 2004 |
Intravitreal triamcinolone acetonide as an adjuvant therapy to panretinal photocoagulation for proliferative retinopathy with high risk characteristics in type 1 diabetes: case report with 22 weeks follow-up.
Topics: Adult; Anesthesia, Local; Combined Modality Therapy; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Follow-Up Studies; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Male; Tomography, Optical Coherence; Triamcinolone Acetonide; Vision Disorders; Visual Acuity; Vitreous Body | 2005 |
Severe steroid-induced glaucoma following intravitreal injection of triamcinolone acetonide.
Topics: Adult; Antihypertensive Agents; Diabetic Retinopathy; Fluorescein Angiography; Glaucoma; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Retrospective Studies; Triamcinolone Acetonide; Vision Disorders; Visual Fields; Vitreous Body | 2006 |
Intravitreal triamcinolone acetonide for serous retinal pigment epithelial detachments in exudative age-related macular degeneration.
Topics: Aged; Anti-Inflammatory Agents; Exudates and Transudates; Female; Humans; Injections; Macular Degeneration; Male; Retinal Detachment; Treatment Outcome; Triamcinolone Acetonide; Vision Disorders; Visual Acuity; Vitreous Body | 2007 |
The effects of posterior subtenon injection of triamcinolone acetonide in patients with intermediate uveitis.
Topics: Adolescent; Adult; Aged; Child; Fascia; Female; Follow-Up Studies; Humans; Injections; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Orbit; Postoperative Complications; Triamcinolone Acetonide; Uveitis, Intermediate; Vision Disorders; Visual Acuity | 1995 |